< Michael A. Gallo Ph.D., D.A.B.T. EOHSI Directory | EOHSI


Michael A. Gallo Ph.D., D.A.B.T.

Professor Emeritus Rutgers UniversityEOHSI – Toxicology
Work EOHSI Room 408 170 Frelinghuysen Rd Piscataway NJ 08854 Work Phone: 848-445-0175 Work Fax: 732-445-4161
Photo of Michael A. Gallo Ph.D., D.A.B.T.

Biographical Info

Dr. Gallo is a Professor in the Rutgers-Robert Wood Johnson Medical School Department of Environmental and Occupational Medicine. He is a Diplomate of the American Board of Toxicology, and a Fellow of the Academy of Toxicological Sciences. Dr Gallo is an Adjunct Professor both in the School of Public Health and in the Department of Pharmacology and Toxicology in the Ernest Mario School of Pharmacy of Rutgers University. He is a founding member of the Environmental and Occupational Health Sciences Institute where he served as Director of Toxicology, and as Director of the NIEHS Center of Excellence. He was the founding Director of the Cancer Institute of New Jersey and Associate Dean for Research. Dr. Gallo is a renowned toxicologist with expertise in the area of dioxins and PCBs, experimental models in pharmacology and toxicology, cytoplasmic and cell surface receptors, hormone biology and mechanisms of hormonal and environmental carcinogenesis. His avocation is History of Toxicology. Dr. Gallo served on several NIH committees including the ALTOX-4 Study Section, Chair of the Board of Scientific Councilors of the National Toxicology Program, and member of the NIEHS Board of Councilors. He also served as Chair of the NCI Centers Review committee, as well as a member of several NAS/NRC Expert committees including Drinking Water and Health; Pesticides in the Diets of Infants and Children; Risk Assessment Methodology; and the National Research Council/Institute of Medicine Roundtable on Environmental Health Sciences, Research and Medicine. He served the US-EPA as a member of the Scientific Advisory Board, and the Dioxin Review Science Advisory Board. Dr. Gallo was Chair of the New Jersey Governor’s Pesticide Control Council, and the New Jersey Cancer Risk Commission. Dr. Gallo serves as a consultant to the academic, government and private sectors.

Research Areas

Dioxins; Experimental Models; Pharmacology and Toxicology; Ocular Toxicity; Cytoplasmic Receptors; Hormones; Mechanisms of Carcinogenesis; Cell Surface Receptors; and Chemical Carcinogenesis

Scholarly Activities

  • 2011: Society of Toxicology Education Award
  • 2001: Chair, Hormonal Carcinogenesis Gordon Research Conference
  • 2000: Ambassador of Toxicology, Mid-Atlantic Society of Toxicology
  • 1985: Chair, Mechanisms of Toxicity Gordon Research Conference
  • 1985: UMDNJ Exceptional Merit Award
  • 1979: Russell Sage College Outstanding Alumni
  • 1971-1972: NIH Post Doctoral Fellow
  • 1968-1971 NIH Pre-Doctoral Fellow

Recent Publications

  1. Metovic, J, Vignale, C, Annaratone, L, Osella-Abate, S, Maletta, F, Rapa, I, Cabutti, F, Patriarca, S, Gallo, M, Nikiforov, YE et al.. The oncocytic variant of poorly differentiated thyroid carcinoma shows a specific immune-related gene expression profile. J. Clin. Endocrinol. Metab. 2020; :. doi: 10.1210/clinem/dgaa655. PubMed PMID:32936917
  2. Vitale, G, Dicitore, A, Barrea, L, Sbardella, E, Razzore, P, Campione, S, Faggiano, A, Colao, A, NIKE, Albertelli, M et al.. From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?. Rev Endocr Metab Disord. 2020; :. doi: 10.1007/s11154-020-09589-y. PubMed PMID:32935263
  3. Ceresetto, JM, Duboscq, C, Korin, J, Fondevila, C, Casais, P, Rossi, A, Scazziota, A, Martinuzzo, M, Aris Cancela, ME, Rosa, C et al.. [Argentine Consensus in effective management of anticoagulation clinics for the use of vitamin k antagonists]. Medicina (B Aires). 2020;80 Suppl 4 :1-26. . PubMed PMID:32897867
  4. Silvestris, N, Argentiero, A, Beretta, GD, Di Bartolo, P, Montagnani, M, Danesi, R, Ferrari, P, D'Oronzo, S, Gori, S, Russo, A et al.. Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper. Crit. Rev. Oncol. Hematol. 2020;154 :103066. doi: 10.1016/j.critrevonc.2020.103066. PubMed PMID:32853883
  5. Eleftheriou, G, Butera, R, Gallo, M, Giampreti, A, Faraoni, L, Contessa, MG, Bacis, G. Lacosamide-induced recurrent ventricular fibrillation: A case report
. Int J Clin Pharmacol Ther. 2020; :. doi: 10.5414/CP203813. PubMed PMID:32831166
  6. Copeland, A, Gallo, L, Weber, C, Moltaji, S, Gallo, M, Murphy, J, Axelrod, D, Thoma, A. Reporting Outcomes and Outcome Measures in Thumb Carpometacarpal Joint Osteoarthritis: A Systematic Review. J Hand Surg Am. 2020; :. doi: 10.1016/j.jhsa.2020.05.024. PubMed PMID:32819777
  7. Mager, LF, Burkhard, R, Pett, N, Cooke, NCA, Brown, K, Ramay, H, Paik, S, Stagg, J, Groves, RA, Gallo, M et al.. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369 (6510):1481-1489. doi: 10.1126/science.abc3421. PubMed PMID:32792462
  8. Hoffmann, S, Pentakota, S, Mund, A, Haahr, P, Coscia, F, Gallo, M, Mann, M, Taylor, NM, Mailand, N. FAM111 protease activity undermines cellular fitness and is amplified by gain-of-function mutations in human disease. EMBO Rep. 2020; :e50662. doi: 10.15252/embr.202050662. PubMed PMID:32776417
  9. Micera, M, Botto, A, Geddo, F, Antoniotti, S, Bertea, CM, Levi, R, Gallo, MP, Querio, G. Squalene: More than a Step toward Sterols. Antioxidants (Basel). 2020;9 (8):. doi: 10.3390/antiox9080688. PubMed PMID:32748847 PubMed Central PMC7464659
  10. Nervo, A, Ragni, A, Retta, F, Gallo, M, Piovesan, A, Liberini, V, Gatti, M, Ricardi, U, Deandreis, D, Arvat, E et al.. Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. J. Endocrinol. Invest. 2020; :. doi: 10.1007/s40618-020-01374-7. PubMed PMID:32743746
Search PubMed
Categories: Faculty, Toxicology
Skip to toolbar